drugset / Trial / NCT03347331
[18F]-F13640 as a New Brain Radiopharmaceutical
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This clinical assay is designed to validate that \[18F\]F13640 as a radiotracer of 5-HT1A functional receptors. A first group of healthy subjects underwent a PET scan with arterial blood sampling to determine the kinetic model of the tracer. A second group of healthy subjects underwent a classical test-retest study (i.e two distant PET scans) to determine the reproducibility of measures.
Timeline
- Start
- 2018-04-23
- Primary completion
- 2021-04-23
- Completion
- 2021-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]F13640 | Diagnostic / imaging agent | 1 mbq/kg | Other |
| Subject | [18F]F13640 | Diagnostic / imaging agent | 150 mbq | Other |